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ABSTRACT
Prevention of Type 2 diabetes (T2D) is clinical service useful to implement on community pharmacy settings (CP). 
The objectives of study were: to determine the risk factors for T2D in adults visiting a community pharmacy; 
to determine and describe component of pharmacists’ interventions (PI) focusing on feasibility of complex 
intervention (CI). A cross-sectional study design and conducted (January 2010 to June 2011) on 20 CP in 
Serbia. Adult population was enrolled (304 patients).The pharmacist trained for implementation of complex PI 
(screening and counseling session). The national Questionnaire for T2D risk estimation was used for screening 
and Intervention check list was design and used for process of counseling. The DEPICT (Descriptive Elements 
of Pharmacist Intervention Characterization Tool) was used to describe the component of CI. High and very high 
risk score was estimated in age group 45-54 (10.80%) forward in age group 55-64 (9.60%); into the cohort 
below 45 year the 59 adults  has low T2D risk score. The average value of PI/per patients was 4.02. From the 
eight domain/component (operational descriptor in DEPICT) the main component are ‘education and counseling’ 
with four type (items) of intervention performed in counseling session. As a conclusion, the pharmacists in CP 
detected and scoring risk of T2D in Serbian adults’ population. The number and type of PI in counseling session 
adequate to participants clinical profile. Feasibility of the CI within the CP in Serbia was proved. For the outcomes 
measurements and impact of PI, a proper endpoint and follow-up study design should be conduct. 
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Diabetes is one of  the leading causes of  
death and disability worldwide, with over 
220 million people affected. It contributes 
to 5% of  all deaths globally and is anticipated 
to increase by more than 50% in the next 
10 years.1,2 Diabetes mellitus (DM) is recog-
nized as a huge burden for any health care 
system. It affects people of  productive age 
and in recent years has also begun to affect 
young people.3
In Serbia about 600.000 people (8.2% of  
the population) have been diagnosed with 
diabetes.  According to the estimations 
of  domestic experts and on the basis of  
the results of  international studies, at least 
Submission Date : 29-06-2015
Revision Date      : 07-09-2015
Accepted Date     : 14-11-2015a half  of  those with type 2 diabetes have 
not been diagnosed and are not aware of  
their disease.4 Serbian national health sur-
veys of  the general population in 2006 and 
international data from 2012 have shown 
an increasing trend in the prevalence of  
diabetes, with reported rates of  5%, and 
12.35%, respectively.5,6 The key risk factors 
identified were: BMI 25 kg/m2, sedentary 
lifestyle, hypertension in young population 
and productive age population in Serbia.5
The majority of  risk factors can be easily rec-
ognized or measured by health care providers 
and/or patients. Although adults 
may be aware that they possess such 
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characteristics, they may not know that clus-
ters of  these factors further amplify the risk of  
diabetes. Several prevention studies have shown that treat-
ment of  pre-diabetes with lifestyle changes can decrease 
the risk of  progression to diabetes considerably.7-9
The Diabetes Prevention Project, which had been 
conducted in the USA demonstrated that for patients 
at high risk for diabetes, lifestyle changes such as loss 
of  7% of  weight and 150 minutes of  walking per week, 
decrease the risk of  diabetes by 58%.7 
There is a growing body of  evidence that shows that 
intervention programs run by health care professionals, in 
ambulatory settings, and with community pharmacists’ 
involvement, were effective at both preventing and 
managing cardiovascular disease (CVD) and diabetes. 
Despite the increasing number of  studies showing that 
pharmacist intervention programs provide a clinical 
benefit and sensitivity in terms of  patients outcomes, 
there are few studies that have examined the concept of  
multidisciplinary health care and collaborative practice in 
the context of  community care settings and with phar-
macist intervention.10-12 
Diabetes management  programs have been implemented 
in pharmacy practice using a range of  different interven-
tion such as educational interventions, counseling,13 risk 
screening,14,15 medication reviews,16 and usually accred-
ited by national professional institutions. The American 
Association of  Diabetes Educators (AADE) published 
the scope and standards for professional performance 
for diabetes educators specifically to address the provision 
of  this care by pharmacists in their practices.17 
Almost every country worldwide has strategies for the 
prevention of  diabetes. In Serbia, a series of  guidelines 
have been adopted, at the national level that is aimed 
at achieving more efficient diabetes care. These are 
the National Guidelines for diagnosis and treatment 
of  Diabetes;18 National Guidelines for Prevention of  
Type 2 Diabetes19 and the National Program for the 
Prevention of  Diabetes and Early Detection of  type 
2 diabetes.20 For the first time, pharmacists’ role in 
prevention of  type 2 diabetes was recognized and 
defined by National Guidelines for Prevention of  Type 2 
Diabetes. This provides a great opportunity for phar-
macists to play an active role in the prevention and 
management of  Type 2 Diabetes and more generally 
for the development of  pharmacy practice in Serbia. 
It has been argued that pharmacists are ideally suited to 
provide preventive care and chronic disease interven-
tions for a number of  reasons. For example, community 
pharmacists are highly accessible health professionals in 
both rural and urban communities and are often available 
without an appointment and beyond the hours of  opera-
tion of  many primary care medical clinics. In addition, 
patients see their pharmacist more frequently than their 
physician. As medicine therapy experts, pharmacists are 
capable of  providing pharmaco therapeutic and edu-
cational interventions and are well positioned to play a 
greater role in primary health care.21 
Clinical pharmacy services commonly include a num-
ber of  different pharmacist interventions and are thus 
considered to be complex health interventions.22 In 
order to fully understand the complexity of  pharmacist 
interventions practice-based research needs well design 
studies and tools to evaluate and describe the impact 
of  clinical pharmacy services on patient outcomes. 
Furthermore, for policy  makers an understanding of  
all components of  the pharmacist interventions, and a 
process road map describing the  setting and resources 
are  important to ensure the quality of  the research 
being used.23,24
Pharmaceutical care, as a professional orientation with 
a patient centered approach is not commonly imple-
mented in community pharmacy practice in Serbia. 
A few local (municipality based) projects have been 
performed, and some international projects are ongoing, 
with specific issue and aims, but identification of  risk 
factors of  diabetes 2 in the pharmacy setting and post-
screening pharmacist intervention was the first study in 
Serbia. 
Following this rationale, our objectives were: to determine 
the risk factors for type 2 diabetes in adults visiting a 
community pharmacy; to determine the number, the 
types and describe the components of  pharmacists’ 
interventions in this context focusing on the feasibility 
of  complex interventions in the community setting. 
MATERIAL AND METHODS 
Study design and setting
This pilot study was approved by the Pharmaceu-
tical Chamber of  Serbia as a part of  the project titled: 
The research of  model and quality of  pharmaceutical 
care service in community pharmacy (approved 12th 
December 2009). This study was designed by a working 
group which consisted of  six members (three members 
from academia and three members from community 
pharmacies). A design was created after reviewing the 
scientific literature and according to professional practice. 
The study had a cross-sectional, multicenter design and 
was conducted from January 2010 to June 2011. It was 
conducted in 20 community pharmacies from all regions 
of  Serbia (four from the northern region Vojvodina, 
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eight from central Serbia, four from Belgrade, two from 
the western region, one from the eastern region, and 
one from the southern region). The pharmacies were 
public and private pharmacies, independent or a part 
of  a pharmacy chain. The manager/owners of  these 
pharmacies accepted our offer to participate in the 
study after written invitations were sent by the principal 
investigator (VKP). The study had two phases: prepara-
tion of  tools and training of  pharmacists (from January 
to May 2010) and project implementation in practice 
(from June 2010 to June 2011). The overall design and 
the tools used in the study were approved by Ethical 
Committee of  the University of  Belgrade, Faculty of  
Pharmacy. 
Tools used in this study
We have used the questionnaire for type 2 diabetes 
risk estimation published by National Program for the 
Prevention of  Diabetes and Early Detection of  type 2 
Diabetes (Appendix 1). This questionnaire consisted of  
eight themes which examined: the demographic charac-
teristics of  adults (age, gender (2 items)), and 1 question 
was asked for each of  the following: body mass index 
(BMI), waist circumference, physical activity, eating of  
vegetables/fruits, intake of  antihypertensive medica-
tions, and previous elevated level of  blood glucose and 
diabetes family history. 
Educational Material (Leaflet)
Based on the existing literature, Educational material 
(a leaflet) was developed by the principal investigator 
(VKP; available from authors on request) to facilitate the 
education of  patients at risk of  diabetes, and to support 
pharmacy based counseling sessions. This leaflet contains 
illustrated, motivational, information for participants 
regarding healthy lifestyle, healthy diet and how to self-
manage their health. 
Intervention Checklist
To evaluate the process of  screening participants for 
type 2 diabetes, a checklist was design by the principal 
investigator (VKP). Face validation was done by two 
pharmacists (one from pharmacy practice and one from 
academia). The checklist was then pilot tested in two 
pharmacy settings (during one week with 20 participants) 
to assess its acceptability in a real setting (Appendix 2). 
The Intervention checklist that was developed is consis-
tent with the nine types of  pharmacist‘s interventions 
for patients at risk of  diabetes. It included counseling 
of  patients about proper nutrition; counseling patients 
about the importance of  physical activity and a healthy 
lifestyle; counseling patients about the importance 
of  an annual preventive health check by their GP; pro-
viding the  health education material (leaflet) to the 
patient; referral of  the patient to the general practitioner 
(GP) based on assessment of  risk; counseling of  
patients about the importance of  weight control; 
recommendations to patients regarding  herbal or tradi-
tional medicines and dietary supplements use; inviting 
patients to come back to the same pharmacy after their 
general practitioner visit; have a telephone communication 
with the patients GP and sending patient to him. All inter-
ventions should be marked on the check list (Appendix 2).
Pharmacist training 
Pharmacists who were involved in the study and 
who recruited participants had to complete a one-day 
competency-based training and workshop. The training 
was accredited by the National Committee for accredi-
tation for Continual Medical Education. The training 
was attended by 30 pharmacists who filled in pre and 
post training tests of  their knowledge in relation to 
diabetes and the study tools. 
The competency-based training focused on developing 
the pharmacists’ knowledge and skills in relation to 
diabetes and the need to communicate and appropri-
ately counsel the target patient population. The set of  
documents which were to be used in this study were also 
presented to the pharmacists during this training with 
full detail explanation and instructions. These documents 
included: A patient written consent-form, Question-
naire for type 2 diabetes risk estimation (Appendix 1), 
an intervention checklist (Appendix 2) and Educational 
material (leaflet) for participants. 
Participants recruitment, data collection and 
pharmacist interventions
The Pharmacists randomly recruited the participants, 
who were willing to participate in the study, over a one 
year period. All of  the participants were informed about 
the study aims and were asked to sign an informed 
consent before participation. The inclusion criteria for 
the study were: healthy or with a chronic disease, aged 
over 18 years. The exclusion criteria were being less 
than 18 years of  age, and adults who were cognitively 
impaired and therefore could not complete the ques-
tionnaire. The recruitment process and communication 
with participants were performed in separate counseling 
areas of  each community pharmacy. Every participant 
was asked to complete the risk assessment questionnaire 
for type 2 diabetes personally. Pharmacists were avail-
able to assist to participants with any questions about the 
questionnaire, to measure waist circumference, and calcu-
late BMI. The risk level was calculated and data recorded 
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in the questionnaire. The pharmacist then counseled the 
participant in accordance with the National program for 
prevention of  diabetes and early diagnoses using the 
appropriate interventions from the set of  nine different 
interventions tailored to the patients estimated risk level. 
Every intervention was then recorded for each patient 
using the Intervention checklist.
Characterizing the Components of Pharmacists 
Interventions
For the purpose of  understanding the depth of  pharma-
cist interventions a qualitative analysis was performed,25 
using the DEPICT (a Descriptive Elements of  Pharmacist 
Intervention Characterization Tool).23 This tool was 
developed to be used as reference guide to compare/
assess the main domains of  the pharmacists interven-
tions. The DEPICT was used here to assess the two 
tools used in our study (Appendix 1 and Appendix 2).23
Data analysis
The cohort was stratified on four age group: 18-45, 
45-54; 55-64; 64. Demographic characteristics and clinical 
data were analyzed using the descriptive statistics. Quan-
titative analysis of  number of  interventions was under-
taken using the chi-square test. The numerical data were 
analyzed using the statistical program SPSS version 
18.0. The description of  components of  pharmacist 
intervention as process of  delivery of  pharmaceutical 
care service, that is the qualitative component of  our 
study, was independently analyzed by an experienced 
researcher (LjT). 
RESULTS
Evaluation of the participants’ risk level for type 
2 diabetes 
Pharmacists from 20 pharmacies recruited 403 partici-
pants. A further 69 eligible people refused to participate 
in the study (response rate 82.88%). Demographic and 
clinical characteristics of  the participants are presented 
in Table 1.
Most of  the participants were women, younger than 45 
years and had healthy lifestyle habits. Two hundred and 
thirty two participants (69.5%) were involved in daily 
physical activity lasting for at least 30 minutes. In all 285 
(85%) participants ate some fruit and vegetables every 
day. A large proportion of  the sample reported risk 
factors for cardiovascular disease.  Antihypertensive 
medications have been taken by 54.7% of  participants 
(Table 1).  About one-third of  the participants (n=117, 
35%) have ever registered a high blood glucose level 
during routine health checks, during illness or preg-
nancy. Also, less than a half  of  the participants had a 
positive family history of  diabetes (46%)  (Table1).
Over 69% of  participants were either overweight (BMI 
range from 25-30) or obese (more than 30) (obesity). 
Approximately 77% of  participants had waist circum-
ference measurements above the recommended values 
(<80 for female and <94 for male gender) (National 
guidelines for obesity, 2004). 
The participants were divided into four age groups, 
according to Questionnaire for type 2 diabetes risk 
estimation, and risk for developing diabetes in the next 
10 years was estimated and results are presented in 
Table 2. Based on the estimated risk degree, the prevalence 
rate of  diabetes in our cohort is 2.69%. Approximately 
10.8% of  participants aged between 45-54 and 9.6% 
of  those aged 55-64 recorded high and very high risk 
scores. In the latter group (55-65 age groups) the moder-
ate diabetes 2 risk score was present in 32 adults (9.6%). 
Interestingly, into the population group aged below 45 
years (37.72% of  our cohort) 59 adults (17.8%)   had 
low and 31 adult (9.3%) had moderate diabetes 2 risk 
scores. 
Determination of the number and type of 
pharmacists’ interventions 
Pharmacist interventions were targeted according to 
risk degree estimated and was based on the interven-
tions listed in the checklist. (Appendix 2). Quantita-
tive results include the absolute measures (number of  
participants and number of  the interventions sorted by 
five categories of  risk) and relative measures (number 
of  pharmacists’ interventions per participants PI/pP). 
These results are presented in Table 3.
The pharmacists made a total of  1328 intervention dur-
ing the study. The results indicated that the number of  
pharmacists’ interventions depended on participants’ 
risk score (365 for moderate and 461 for high risk level 
patients). Using the relative measurement unit (PI/pP) 
we were able to assess the quality of  pharmacist care 
related to clinical markers e.g. risk factors. For low and 
slight risk level participants a rate of  2.27 and 3.85 inter-
ventions per person were estimated. The average value 
of  PI/pP was 4.02, and in patients with moderate, high 
and very high risk the estimated value was 5.28, 5.42 and 
3.55 PI/pP, respectively.  Incidentally, a small number 
of  interventions were done to the participants with very 
high risk factor scores for diabetes 2 (32 interventions 
for 9 participants), however, the appropriate types of  
intervention have been done with this group. There is 
a statistically significant difference between number of  
pharmacists interventions and number of  participants 
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related to risk level groups (Chi sq=31.25, p<0.001). 
Among the nine types of  pharmacists’ interventions for 
early screening of  type 2 diabetes, an important inter-
vention involved ‘referring patients to a general prac-
titioner (GP). In total 97 participants were referred to 
a GP, of  these 52 with a high risk score and 38 with a 
moderate risk score. The educational materials (leaflet) 
were handed out to 206 participants (61.7% of  study 
population, e.g. 15.34 % of  total interventions) (Table 3). 
Description of components of pharmacist 
interventions 
The classification of  the nine interventions for preven-
tion of  type 2 diabetes was designed based on pharmacy 
practice in real word settings in Serbia within context 
of  operational management and environment and 
resources. It was developed for the purpose of  evaluation 
of  the processes associated with of  the delivery of  com-
plex clinical pharmacy services. A qualitative description 
of  the components (domains) of   the “pre-process” 
that is, the estimation of  risk scores (screening) and the 
“process itself   ” that is pharmacist interventions (coun-
seling) was performed. Two tools (Questionnaire and 
Intervention checklist) used in this study were described 
using the DEPICT Tool.23 The results are presented in 
Table 4. 
The DEPICT tool consist of  12 domains (from A to M). 
Domains A to D form a general descriptor, two of  these 
domains A. contact with patients and D. target popula-
tion, can be seen in the 1st (demographic) and in the 
2nd (clinical data q2-q8 and) parts of  the Questionnaire. 
The other two general domains, that is, B. timing and C. 
setting are present in both our tools (Questionnaire and 
Intervention checklist). 
Operational descriptors of  components of  the clinical 
pharmacy service (domains E to M) match with the 
‘construct’ of  tools used for the evaluation of  complex 
pharmacist interventions (screening and counseling). 
Domain E. clinical data sources, corresponded with the 
clinical part of  Questionnaire (that is q2-q8); Domain 
F., assessment comprises the pharmacist’s calculation of  
patients risk degree and profile. Knowing the patient’s 
profile allowed the pharmacist to offer a tailored set of  
interventions, of  good quality, which should be evalu-
ated in follow-up patients visit (e.g. life style changes) 
or by patients’ satisfaction measurement. Domain G. 
pharmacist’s autonomy clearly meshes with a personal 
decision about the number and type of  interventions 
delivered to each patient; H. pharmacist communica-
tion, this can be seen in activities associated with rec-
ommendations for supplement use and communication 
with GPs. Domain I. support resources, this comprised 
the education material that is the leaflet. J. education and 
counseling domain comprised  four types of  counseling 
activity/interventions; domain L. follow-up, involves 
the  invitation of  patients to come back to the same 
pharmacy; domain M. other actions (usually supportive 
activity) was of  two types of  interventions  e.g. recom-
mendation of  some product and referral patients to 
GPs.
DISCUSSION
In the last few years different pharmaceutical care services 
have been offered through  community pharmacies in 
Serbia either as local pharmacy projects, or as a part 
of  pilot projects in public health campaigns (counseling 
patients about diabetes prevention, counseling of  
healthy life styles to prevent obesity, counseling asthma 
patients).26-28
Our study is the first study, a pilot study, in Serbia 
focusing on type 2 diabetes screening. As well this is 
the first study with the specific intention of  describing 
the components, and processes associated with complex 
pharmacy care services provided in community phar-
macy settings for those at risk of  type 2 diabetes. Our 
study provided an opportunity to conduct a screening 
program for type 2 diabetes in pharmacy settings using 
a risk assessment questionnaire. Participants were targeted 
from the labor active population, and so an early recog-
nition of  the extent of  risk was important for prevention 
of  diabetes especially in this population. 
Involvement of  pharmacists in screening for type 2 
diabetes can increase the early detection of  the at  risk 
population and has the potential to slow progression 
to micro vascular and macro vascular complications.29 
Several studies from one  Australian scientific group 
have addressed the issue of  patients’ satisfaction with 
pharmacists’ service in diabetes disease management, 
satisfaction with self-management, and satisfaction with 
knowledge 14,30 have shown the effectiveness of  a com-
munity pharmacy delivered diabetes care service, using 
a step screening model. In our study we recognized and 
used a model of  complex intervention (screening and 
counseling). 
According to data obtained from the Institute of  Public 
Health of  Serbia for 2012 the incidence rate of  type 2 
diabetes per 100.000 inhabitants were 208.9, 329.7, 
473.5, 559.5, 638.7 in 2012, in population age groups 
45-49, 50-54, 55-59, 60-64, 65-69, respectively 4. In the 
6th Diabetes Atlas a prevalence rate of  type 2 diabetes in 
Serbian population was 2.89 which were near the preva-
lence rate estimated in our study (2.69). That reassured 
us that the patient sampling was accurate and the design 
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of  our pilot study had been properly done. The most 
significant population for the prevention of  diabetes 
is the 45 to 54 age group (29.34% of  our study). This 
compares with the recent Hungarian diabetes preven-
tion study with an average age 52.8332 and in a Nova 
Scotia pre-diabetes study the average age of  the study 
population was approximately 57 year.33 
The prevalence rate detected in our study was lower 
than similar published studies. Namely,   the results from 
a pilot screening program in England show an overall 
prevalence of  4.08% including 0.54% undiagnosed.34 
One possible explanation for these differences between 
country could be related to a healthier lifestyle estimated 
in our study group, which is also supported by national 
epidemiologically data from public health survey.5 Pop-
ulation level approaches and targeted (opportunistic) 
screening approaches have been used in many studies. 
We used an opportunistic screening approach to health 
prevention in our study. The screening of  patients was 
evaluated and risk level estimated by pharmacists and 
Table 1: Demographic characteristics of participants and risk factor estimation a







< 45 126 37.7
       45 – 54 98 29.3
55-64 97 29.0
> 65 13 3.8
Risk factors: participants answering “yes” to a risk factor on the 
assessment tool
BMI (kg/m2)b
< 25 103 31.8
25-30 133 39.8
> 30 98 29.3
Waist circumference (cm)c
< 94 (M)        < 80 (F) 75 22.4
94-102 (M)   80-88 (F) 93 27.8
> 102 (M)      > 88 (F) 166 49.8
Have physical activity during the day 30 minutes 232 69.5
Every day eat vegetables and fruit 285 85.0
Ever taking antihypertensive medication 183 54.7
Ever measured high blood glucose level  in routine examination, during 
illness or pregnancy
117 35.0
Positive family history 154 46.0
aQuestionnaire for type 2 diabetes risk estimation (see Appendix 1)
bparticipant fill the weight (kg) and height (m) in the questionnaire form and pharmacist calculating BMI-Body mass index 
cpharmacist measured the circumference (cm)  
Table 2: Evaluation of the risk degree * according to age groups
Age groups n (% )
Degree of risk < 45 45-54 55-64 > 65
Low 59 (17,8) 10 (3,0) 4 (1,2)
Slight 31 (9,3) 35 (10,5) 28 (8,4) 4 (1,2)
Moderate 18 (5,4) 17 (5,1) 32 (9,6) 2 (0,6)
High 16 (4,8) 34 (10,2) 29 (8,7) 5 (1,5)
Very high 2 (0,6) 2 (0,6) 3 (0,9) 2 (0,6)
*Risk degree was calculated using the Questionnaire for type 2 diabetes risk estimation (Appendix 
1). According to the questionnaire risks degree were divided into five categories (proportion of 
people who will develop DM within 10 years):  Low ≤ 7 points, one of 100 people; Slight 7-11 points, 
one of 25 people; Moderate 12-14 points, one of 6 people; High 15-20 points, one of 3 people; Very 
high ≥ 20 points, one of 2 people.
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pharmacists’ interventions were adequately performed 
according to a risk score.
A high risk of  diabetes was detected in the age groups 
45-54 and 55-64. Two participants from the 45-54 age 
grouping and three from the 55-64 year age group were 
at a very high risk of  diabetes (see Table 2). This is a 
working population that could be healthy and more 
socio-economically productive. Therefore, this is an impor-
tant sign for the need to implement broader, community 
based preventive health services in Serbia which should 
allow a timely diagnosis and help prevent the type 2 dia-
betes. Community based pharmacists are ideally located 
to provide this type of  service. In a health technology 
assessment of  pharmacists’ impact on clinical outcomes, 
it was concluded that screening for late complications 
associated with diabetes could reduce the occurrence of  
retinopathy by 50% as well as reduce foot-related prob-
lems.29
Pharmacists, at the primary health-care level, have an 
important role in the prevention and treatment of  
chronic, non-communicable diseases because of  their 
direct contact with patients. The role of  pharmacists 
has been recognized in the National Guidelines for 
Type 2 Diabetes Prevention, but not implemented in 
practice enough. There is a need to encourage pharma-
cists in order to involve them in all national and local 
screening programs, as well to create national projects 
and programs. From the perspective of  management of  
metabolic syndrome, population level approaches, and 
those targeted at people at high-risk, need to be bal-
anced. A small reduction in risk in a large number of  
people may prevent many more cases, than treating a 
Table 3: Number of participants (patients), interventions and types of pharmacists’ interventions related to risk 
degree* group
Risk degree* low slight moderate high very high Total 
Number of participants (%) 73 (21.86) 98 (29.34) 69 (20.66) 85 (25.45) 9 (2.69) 334 (100.00)
Number of pharmacists’ 
interventions, n (%)
166 (12.36) 319 (23.75) 365 (27.18) 461 (34.33) 32 (2.38) 1343 (100.00)
Number of pharmacists’ 
interventions/ Number of 
participants (PI/pP)
2.27 3.25 5.29 5.42 3.55 4.02 
(average)
Type of intervention, 
n intervention (% of total 
intervention this type  )
Total interventions by type
n  (% of all interventions)
1. Counseling of patients about 
proper nutrition 60 (20.3) 83 (28.1) 66 (22.4) 80 (27.1) 6 (2.0) 295 (21.965)
2. Counseling patients about 
the importance of continued 
physical activity and healthy 
lifestyle
61 (20.7) 84 (28.5) 64 (21.7) 80 (27.1) 6 (2.0) 295 (21.965)
3. Counseling patients about 
the annually preventive  health 
check by  their GP 
4 (3.8) 80 (75.5) 11 (10.4) 11 (10.4) 0 (0.0) 106 (7.89)
4. Providing the health 
education material (leaflet) to 
the patients 
39 (18.9) 58 (28.2) 45 (21.8) 61 (29.6) 3 (1.5) 206 (15.34)
5. Referral of patients to the GP 0 (0.0) 2 (2.1) 38 (39.2) 52 (53.6) 5 (5.2) 97 (7.22)
6. Counseling patients about 
the importance of weight 
control
2 (1.3) 6 (3.9) 61 (39.9) 78 (51.0) 6 (3.9) 153 (11.39)
7. Recommendation to 
patients for herbal or traditional 
medicines and dietary 
supplements use
0 (0.0) 5 (11.4) 30 (68.2) 9 (20.5) 0 (0.0) 44 (3.28)
8. Invite patients to come back 
to the same pharmacy after 
GP visits
0 (0.0) 1 (0.8) 50 (37.9) 75 (56.8) 6 (4.5) 132 (9.83)
9. Have a telephone 
communication with the 
patient’s GP and sending 
patient  to him 
0 (0.0) 0 (0.0) 0 (0.0) 15 (100.0) 0 (0.0) 15 (1.12)
Total, n (%) 166 (12.36) 319 (23.75) 365 (27.18) 461 (34.33) 32 (2.38) 1343 (100.00)
* Risk of developing type 2 diabetes in the next 10 years: Low ≤ 7 points, one of 100 people; Slight 7-11 points, one of 25 people; Moderate 12-14 points, one of 6 people; 
High 15-20 points, one of 3 people; Very high ≥ 20 points, one of 2 people. GP-general practitioner.
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small number at higher risk.35 Pharmacists can provide a 
set of  numerous interventions tailored to the individual 
patients profile and level of  risk.
In our study pharmacists informed patients about 
proper nutrition, as well as the importance of  continued 
physical activity and healthy lifestyle. Lifestyle advice 
from pharmacists can have a positive effect on the risk 
factors for diabetes and other non-communicable 
disease.36 The positive influence of  educational sessions 
and written material (leaflet) on prevention, health pro-
motion and motivation of  the patients to improve their 
health has also been shown.15 The support of  patients 
being managed with diabetes involves different types of  
intervention such as a medication adherence, identifi-
cation of  medication problems or lifestyle advice (e.g. 
exercises, diet, and foot care). Our results of  the num-
ber and types of  intervention are in agreement with 
existing literature, however, there was a the relatively 
low proportion (61,7%) of  patients provided with the 
education leaflet. A possible explanation for this result 
is lack of  time, or awareness of  the usefulness of  sup-
portive tools.
In Hungary, a National Committee on pharmaceutical 
care completed a one year project implementing a diabe-
tes prevention program in pharmacies. A total of  22.398 
citizens from all over Hungary evaluated by pharmacist 
intervention. The conclusion was that pharmacists had 
an active role to play in diabetes prevention and pharma-
cists were well placed to identify individuals at high risk.32 
During project period, the pharmacists sent nearly 20% 
of  the patients to physicians, thus facilitating an early 
recognition of  diabetes in several patients. In our study 
29.04% patients were referred to the GP by pharmacist 
intervention. This is because we used a targeted screening 
approach, contrary to the population approach used in 
the previously mention study. A marked improvement 
in self-monitoring of  blood glucose in type 2 diabe-
tes patients in the German population resulted from 
Table 4: Description of component (domain) of  complex pharmacist’s intervention (screening and counseling) 
using DEPICT 23




A. Contact with the patient demographic 
1st part of Questionnaire 
B. Timing of the intervention at the regular visit (drug dispensing) after screening 
time spend on counseling * 
C. Setting of the intervention community pharmacy community pharmacy
D. Target population Estimated risk score 
2nd part of  Questionnaire 
E. Clinical data sources 2nd part of  Questionnaire
F. Assessment pharmacist calculation of patients risk degree -assessment of patients profile; 
-life style changes**
-patients satisfaction***
G. Pharmacist’s autonomy personal decision of number and type of 
intervention for every patients.
H. Pharmacist communication -communication with patients; 
-communication with GP.
I. Support resources provided 
by the pharmacist 
distribution of health education material-leaflet.
J. Education and counseling four types of intervention at counseling session:
-about proper nutrition
-about the importance of continued physical 
activity and healthy lifestyle 
-about the annually preventive health check by 
their GP 
-about the importance of weight control 
L. Follow-up invitation of patients to come back to the same 
pharmacy.
M. Other actions -recommendation of some product;  
-referral patients to GP.
*time spend on counseling - the data collected from a small number of patients ( ≤10%) and not included in study.  
**life style changes - assessment of behavior’ s changes possible through the follow up visit that had not being design in our study; assessment of patient profile 
included planning of set of intervention for counseling session considering lifestyle advices. 
***patients satisfaction – the data collected but not included in this study.
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Appendix 1
QUESTIONNAIRE FOR TYPE 2 DIABETES RISK ESTIMATION
          Pharmacy ____________
         No. _____________
         Date _____________
Full name: _____________________________________________
Sex:  M      F
1. AGE 6. Have you ever taken antihypertensive medicines?
Points          Answers
                    < 45
2                  45-54
3                  55-64
4                  > 64
Points            Answers
1                    No 
2                    Yes
2. HEALTH PARAMETERS
Body weight in kg _________
Height in m2 _________
Body mass index: 
Points        Answers
0                < 25
1                25-30
3                > 30
7. Have you ever been measured high level of  glucose 
in blood (during routine examination, illness or in preg-
nancy)?
3. WAIST CIRCUMFERENCE (cm)
Points              Male           Female
    0                  < 94           < 80
    3                  94-102        80-88
    4                  > 102          > 88
Points           Answers
   0                No
   5                Yes
4.  PHYSICAL ACTIVITY DURING THE DAY 
(at work or during the break, including the nor-
mal daily activity) minimum 30 min
Points            Answers
1                    Yes
2                     No
8. Has anybody in your family suffered or suffers from 
diabetes?
Points         Answers
   0              No
   3                Yes (grandfather, grandmother, aunt, uncle, 
but not first line relatives (not parents, brothers, sisters 
or children)) 
(parents, brothers, sisters or a child)
5. HOW OFTEN DO YOU EAT VEGETABLES 
OR FRUIT?




Risk factors for diabetes type 2 in the following 10 years 
are:




1 of  100 persons will develop diabetes 
7-11 Slight 
1 of  25 persons will develop diabetes 
12-14 Moderate
1 of  6 persons will develop diabetes 
15-20 High
1 of  3 persons will develop diabetes 
> 20 Very high
1 of  2 persons will develop diabetes
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pharmacists’ interventions is reported in a study done 
by Muller et al.37 In this study it was shown that com-
munity pharmacies specializing in diabetes care were 
able to provide service in self-monitoring of  blood glu-
cose with better outcomes for patients. The study found 
that patients accepted pharmacists’ intervention in the 
pharmacy and also wanted to take a more active role in 
managing their health care.37 The former study has been 
design as an intervention study with follow up over time 
from base line. This is quite a different approach to our 
opportunistic screening approach in diabetes prevention 
with post-screening cognitive service intervention (that 
is with complex intervention). In systematic reviews of  
diabetes quality improvement interventions38 there is 
consistent evidence to indicate that a number of  inter-
ventions, for example, patient education and support, 
telemedicine, and provider role changes, appeared to 
improve diabetes quality of  care. Also, there was some 
evidence that tailoring interventions to specific cultural 
or age groups might be of  benefit to the effectiveness 
of  the treatment strategy.38 Considering this, pharmacists 
in our study provided appropriate, individually targeted 
interventions, provided good knowledge and clinical 
skills.
Our qualitative analysis was designed to provide a better 
understanding of  complexity of  pharmacy services as a 
whole, and particularly counseling service for patients 
with estimated diabetes risk. The DEPICT tool are 
useful in that it allowed us to describe components 
(domains), of  some key elements of  the process that 
we recorded and documented during the interven-
tion, but  in real word setting in our pilot study. This 
provides additional support and recommendations 
for researchers of  pharmacy practice to use DEPICT 
tool as reference guide. To some extent the tool used 
in our study may be useful for the evaluation of  quality 
in future studies of  pharmacist counseling services. 
For the outcomes measurements (clinical, humanistic, 
or economic) and impact of  pharmacist intervention a 
proper endpoint and follow-up study design should be 
obligatory. The previous suggestion to pharmacy prac-
tice researchers is primarily based on experience from 
our study, the professional and academic practice of  
authors and affected by systematic reviews of  Charrois 
Appendix 2 Pharmacy ____________
       No. _____________
       Date _____________
INTERVENTION CHEKLIST
Please circle the intervention that you offered to patients according to their diabetes 2 risk degree (number of  points 
estimated by Questionnaire for type 2 diabetes risk estimation)
P PHARMACISTS INTERVENTIONS
1. Counseling of  patients about proper nutrition
2. Counseling patients about the importance of  continued physical activity and healthy lifestyle
3. Counseling patients about the annually preventive health check by their general practitioner (GP) 
4. Providing the health education material (leaflet) to the patients
5. Referral of  patients to the general practitioner* (GP) 
6. Counseling patients about the importance of  weight control
7. Recommendation to patients for herbal or traditional medicines and dietary supplements use
8. Invite patients to come back to the same pharmacy after general practitioner (GP) visits 
9. Have a telephone communication with the patient’s general practitioner (GP) and sending patients to 
him* 
*patients with high or very high risk degree
Name (signature)  of  pharmacist: ____________________________
Time (min) spend on estimation of  risk score and counseling ___________
Tasic et al., Identification of Risk Factors for Diabetes Type 2 and Components of Pharmacists' Interventions
100 Indian Journal of Pharmaceutical Education and Research | Vol 50 | Issue 1 | Jan-Mar, 2016
T. et al.31 Indeed, we followed the Weinberger et al.39 
recommendation that the ‘dose’ of  health service inter-
vention should be quantified wherever possible, as well 
clearly defining the intervention and setting. Our find-
ings provide a credible and feasible model for the future 
of  pharmacy counseling services in the prevention of  
diabetes type 2 in Serbia. The risk assessment question-
naire for type 2 diabetes was suitable for pharmacists 
and for use in community pharmacy settings. The classi-
fication of  the types of  pharmacists’ interventions used 
in our study could be useful for further development 
of  pharmacy services in primary health care.  Care-
ful organization of  public health services within the 
community pharmacy setting, as well as the clinical, 
social and economic outcome measurements have been 
the imperatives for achieving citizens’ health. The litera-
ture relevant to screening for diabetes has indicated that 
mass screenings are not necessarily more cost-effective 
than the recommended opportunistic screenings, possibly 
performed together with screenings for other lifestyle 
diseases.29 This is an excellent chance for the pharma-
cists and community pharmacy to get involved and be 
proactive with other health care professionals to modu-
late preventive health services and centers.
A growing number of  pharmacists’ interventions that 
were offered to patients according to their risk score 
presented a great opportunity for pharmacists to prevent 
type 2 diabetes. Counseling patients could prevent new 
diabetes patients, or help in early diagnosis of  diabetes 
type 2, especially in patients from the labor population. 
LIMITATIONS
This study had several limitations. The national Ques-
tionnaire for type 2 diabetes risk estimation collects the 
data from participants about BMI, age and waist circum-
ference in categories rather than as precise estimations of  
these values. The study was conducted in a small number 
of  pharmacies which were well geographically distrib-
uted. A small number of  pharmacies were included from 
Belgrade which is the capital and has the most number 
of  pharmacies that serve about 23% of  the Serbian pop-
ulation and so may have been under-represented.
CONCLUSION
To summarize, Pharmacists have an important role 
in public health particularly to raise awareness, pro-
vide access to screening to identify those at risk, and 
make early intervention in chronic disease management 
possible40 On the whole, the development and imple-
mentation of  complex interventions to improve health 
raises issues about the nature and composition of  such 
intervention. Hence, the results of  our pilot study 
support pharmacists’ efforts in developing the future 
model of  service of  “Prevention of  Type 2 Diabetes in 
Pharmacies” in Serbia. The risk assessment question-
naire for type 2 diabetes was suitable for pharmacists 
and community pharmacy settings to detected risk lev-
els in the adult population. The number and type of  
pharmacist interventions undertaken in counseling ses-
sions were found to be adequate to participants clini-
cal profile and practitioners balanced the population 
and opportunistic approaches. From the eight domains 
(operational descriptor of  clinical pharmacy service 
in DEPICT) the main component are ‘education and 
counseling’ with four type (items) of  intervention per-
formed in post-screening counseling service of  adult 
population. The tools used in our study are feasible for 
further development of  the clinical services in commu-
nity pharmacy, certainly with follow-up in study design.
Finally, the careful design of  complex interventions and 
modeling of  the preventive services within the commu-
nity pharmacy setting, with the clinical, social and eco-
nomic outcome measurements are equally important 
processes and it should operate in parallel with pharmacy 
practice research, which is a relatively new field, with the 
potential to have a huge impact on the contemporary 
healthcare system.
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